New hope for stomach cancer patients when immunotherapy fails
Disease control
Recruiting now
This study tests a new combination of drugs for people with advanced stomach cancer that got worse after initial immunotherapy. The treatment includes a targeted therapy (fruquintinib), chemotherapy (nab-paclitaxel), and a new immunotherapy (iparomlimab and tuvonralimab). The goa…
Phase: PHASE2 • Sponsor: Dai, Guanghai • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC